In recent years, there have both been many challenges and advancements in the treatment of ADHD and substance use disorder (SUD) that significantly influence the way advanced practice professionals navigate day-to-day practice.

As part of ongoing efforts to address the epidemic of opioid overdose deaths, New York State has established educational requirements to raise healthcare provider awareness of the risks associated with prescribing and taking opioid pain medications.

Opioid analgesics are approved by the FDA for the treatment of moderate or severe pain. However, individual patients differ greatly in clinical response to different opioid analgesics, and patient populations show widely variable response to the same opioid and dose.

Opioid analgesic medications can bring substantial relief to patients suffering from pain.